Inhibitory Effect of Abatacept on Large Joint Damage in Rheumatoid Arthritis Patients with or Without Concomitant Methotrexate: a Retrospective Multicenter Analysis of 12 Months of Abatacept Treatment in Routine Clinical Practice

Trial Profile

Inhibitory Effect of Abatacept on Large Joint Damage in Rheumatoid Arthritis Patients with or Without Concomitant Methotrexate: a Retrospective Multicenter Analysis of 12 Months of Abatacept Treatment in Routine Clinical Practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2015

At a glance

  • Drugs Abatacept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top